LIXTE recently announced advances in its approach to cancer therapy through its proprietary compound LB-100 Alongside clinical development news, LIXTE is…
Mass General Brigham researchers have developed a new AI model that can estimate brain age, assess a patient’s risk of developing dementia, and help predict survival…
Investors are responding positively to Meta’s decision to keep increasing artificial intelligence spending, even as fears grow that the AI boom could…
LIXTE Biotechnology recently acquired Liora Technologies, and the acquisition includes Liora’s proprietary LiGHT system This system provides several advantages over…
LIXTE’s lead compound, LB-100, targets PP2A, a central regulator of cancer cell survival and treatment resistance Clinical programs are designed…
Although cancer immunotherapy has transformed treatment for many patients, the promise of effective immunotherapy falls short for many patients. Scientists now believe they…
Power availability and control are emerging as binding constraints on AI data center growth, with efficient energy control now seen…
ParaZero entered the Cyprus market via a reseller agreement with homeland security specialist Lella Kentonis The firm’s counter-UAS technologies are…
The new decoder leverages transformer-based neural network architecture to generalize across multiple quantum error correction code families and noise profiles.…
Scientists have designed a new class of nanoparticles that can actively remove harmful proteins from the body, a step that could reshape how…